Try our Advanced Search for more refined results

April 24, 2009

Reckitt Benckiser Inc. v. Watson Laboratories, Inc. - Florida et al

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. February 18, 2011

    Watson's Generic Mucinex Doesn't Infringe, Judge Says

    A federal judge in Florida ruled Friday that Watson Laboratories Inc.'s generic version of Mucinex has a different formulation than Reckitt Benckiser Inc.'s blockbuster expectorant and therefore does not infringe an asserted patent.

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!